Mutation burden and other molecular markers of prognosis in the QUASAR2 clinical trial of colorectal cancer treated with curative intent (Lancet Gastroenterology and Hepatology, 2018)

(untitled) - Domingo, E; Camps, C; Kaisaki, P; Parsons, M; Mouradov, D; Pentony, M; Makino, S; Palmieri, M; Ward, R; Hawkins, N; Gibbs, P; Askautrud, H; et al.